http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102268003-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7641d8ec4b289baa8268f4936e0e4635
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-22
filingDate 2011-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d109f4c495d9316866bdf5e6d7bf844f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce989168e8e67f4c14d7818fd8e8cb85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0666fe875444499e96fab1d78f9b3323
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_403f2d0354d529b40f293f6b74d8e04e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c96fa5d3383b7a479d7eba4fe4ac1c56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e25bf74e3c7129de35e36e858f8f8ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb2ac6fb38703569ab76b6ca778e7ea8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6225fc56c3a5e5c0d49f4c7fc5aab346
publicationDate 2013-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102268003-B
titleOfInvention Unsymmetrical poly-substituted porphyrin gold (III) type anticancer compound and preparation method thereof
abstract The invention discloses an unsymmetrical poly-substituted porphyrin gold (III) type anticancer compound and a preparation method thereof, belonging to the technical field of preparation of medicaments. The preparation method comprises the following steps of: making unsymmetrical poly-substituted porphyrin serving as a ligand react with potassium chloroaurate in an acetic acid system; and performing ion exchange through lithium chloride to obtain the anticancer compound. In the preparation method, different high-polarity radicals are introduced into a porphyrin ring, so that the symmetrical characteristic of molecules is improved, the targeting effect of a poly-substituted tetraphenyl chloride porphyrin gold compound on cancer cells is enhanced, and the dissolving capacity of the compound in water can be facilitated. The compound synthesized with the method has a remarkable inhibiting effect on SGC-7901 and SMMC-7721 tumor cells in vitro and is superior to cis-platinum serving as a positive control medicament, the highest inhibiting rates of 4c and 4a are higher than a pilot compound G0, the IC50 of 4a is less than G0, and higher targeting selectivity is shown. The unsymmetrical poly-substituted porphyrin gold (III) type anticancer compound prepared with the method has high anti-cancer activity, small toxic or side effect and simple, convenient and practicable preparation process, and is suitable for industrial production.
priorityDate 2011-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9989226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538728
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24436
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161429450
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424435111
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551130
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425553238
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID82528
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453511857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450422860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583194
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453277883
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449010502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1132
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID433294
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10882
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521555
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7725
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454141097
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514890
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535155
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID82528
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538528
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559508
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158227772
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451273444
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451816491
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517045
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485223053
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136091541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68179
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152778597
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451818717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28133
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350

Total number of triples: 70.